All Stocks/Healthcare/GMED

GLOBUS MEDICAL INC

GMED
HealthcareMedical Devices Website
Price ChartPowered by TradingView
Ask about GMEDAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Citadel
Ken Griffin
2.63M$229.36MNEW
Marshall Wace976K$85.21MNEW
D.E. Shaw
David Shaw
88K$7.70MNEW
Politicians who traded GMEDFrom Senate & House PTRs
PoliticianDateTypeAmount
Gilbert Cisneros
D-CA
2026-08-19purchase$15k – $50k
Lisa McClain
R-MI
2025-06-17purchase$1k – $15k
Josh Gottheimer
D-NJ
2019-07-26purchase$1k – $15k
Thomas R Tillis2015-02-13sale$1k – $15k
About GLOBUS MEDICAL INC

Globus Medical Inc. is a leading global musculoskeletal technology company that develops and commercializes implantable devices, biologics, accessories, and surgical instruments for spinal, orthopedic trauma, neurosurgical, and joint reconstruction procedures. The company focuses on solving unmet clinical needs through innovative solutions, including its comprehensive spine and orthopedic portfolios, regenerative biologics, and enabling technologies such as robotics, navigation systems, and the Excelsius™ platform. Globus Medical provides world-class education and clinical support via its Musculoskeletal Education and Research Center, offering training in cadaveric labs, research facilities with biomechanical testing, and peer-to-peer programs to advance patient outcomes. It emphasizes exceptional surgeon response, rapid product innovation through iterative design cycles, and collaboration with healthcare professionals to enhance surgical accuracy, minimize invasiveness, and improve care efficiency. Founded in 2003 and headquartered in Audubon, Pennsylvania, Globus Medical plays a vital role in the medical device industry by delivering technologies that promote healing for patients with musculoskeletal disorders.

CEO
Mr. Keith W. Pfeil
Employees
6,000
Quick Facts
Exchange–
SectorHealthcare
IndustryMedical Devices
Market Cap–
Key Dates

Earnings calendar coming soon. Subscribe to get notified when GMED reports next.

Get earnings alerts →